Mainz Biomed N.V.
MYNZ
$4.37
-$0.365-7.72%
| 12/31/2021 | 09/30/2021 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | -80.83% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | -80.83% | |||
| Cost of Revenue | 0.00% | 158.49% | |||
| Gross Profit | 0.00% | -124.82% | |||
| SG&A Expenses | 0.00% | 1,151.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 661.87% | |||
| Operating Income | 0.00% | -2,106.43% | |||
| Income Before Tax | 0.00% | -2,477.45% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | -2,477.45% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | -2,477.45% | |||
| EBIT | 0.00% | -2,106.43% | |||
| EBITDA | -0.11% | -2,297.62% | |||
| EPS Basic | 0.00% | -487.76% | |||
| Normalized Basic EPS | 0.00% | -384.18% | |||
| EPS Diluted | 0.00% | -487.76% | |||
| Normalized Diluted EPS | 0.00% | -384.18% | |||
| Average Basic Shares Outstanding | 0.00% | 338.53% | |||
| Average Diluted Shares Outstanding | 0.00% | 338.53% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
